SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950133-07-003378
Filing Date
2007-08-09
Accepted
2007-08-09 16:59:35
Documents
9
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q w38182e10vq.htm 10-Q 290893
2 EX-10.1 w38182exv10w1.htm EX-10.1 87267
3 EX-10.2 w38182exv10w2.htm EX-10.2 33530
4 EX-10.3 w38182exv10w3.htm EX-10.3 39060
5 EX-10.4 w38182exv10w4.htm EX-10.4 36743
6 EX-31.1 w38182exv31w1.htm EX-31.1 8396
7 EX-31.2 w38182exv31w2.htm EX-31.2 8465
8 EX-32.1 w38182exv32w1.htm EX-32.1 4110
9 EX-32.2 w38182exv32w2.htm EX-32.2 4143
  Complete submission text file 0000950133-07-003378.txt   513983
Mailing Address 508 LAPP ROAD MALVERN PA 19355
Business Address 508 LAPP ROAD MALVERN PA 19355 4849131200
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 071041444
SIC: 2836 Biological Products, (No Diagnostic Substances)